| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| von Willebrand Factor | 77 | 2024 | 680 | 7.440 |
Why?
|
| P-Selectin | 68 | 2018 | 599 | 5.290 |
Why?
|
| Neutrophils | 61 | 2024 | 3785 | 5.130 |
Why?
|
| Blood Platelets | 64 | 2020 | 2479 | 4.470 |
Why?
|
| Thrombosis | 44 | 2022 | 2956 | 3.530 |
Why?
|
| Venous Thrombosis | 19 | 2024 | 1321 | 3.030 |
Why?
|
| Platelet Adhesiveness | 20 | 2012 | 154 | 2.670 |
Why?
|
| Hydrolases | 9 | 2018 | 146 | 2.340 |
Why?
|
| ADAM Proteins | 14 | 2013 | 243 | 2.280 |
Why?
|
| Mice, Inbred C57BL | 102 | 2024 | 22381 | 2.060 |
Why?
|
| Mice, Knockout | 78 | 2024 | 14485 | 1.870 |
Why?
|
| Metalloendopeptidases | 12 | 2016 | 385 | 1.830 |
Why?
|
| Endothelium, Vascular | 49 | 2012 | 4428 | 1.780 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 15 | 2014 | 144 | 1.640 |
Why?
|
| Mice | 176 | 2024 | 82074 | 1.610 |
Why?
|
| Neutrophil Activation | 6 | 2021 | 180 | 1.460 |
Why?
|
| Inflammasomes | 7 | 2024 | 540 | 1.410 |
Why?
|
| Platelet Membrane Glycoproteins | 19 | 2004 | 283 | 1.390 |
Why?
|
| Leukocytes | 28 | 2013 | 2034 | 1.390 |
Why?
|
| E-Selectin | 26 | 2011 | 578 | 1.300 |
Why?
|
| Animals | 216 | 2024 | 169408 | 1.290 |
Why?
|
| Neutrophil Infiltration | 9 | 2024 | 395 | 1.290 |
Why?
|
| Histones | 14 | 2022 | 2603 | 1.270 |
Why?
|
| Arthritis | 2 | 2023 | 684 | 1.140 |
Why?
|
| Blood-Brain Barrier | 9 | 2018 | 1036 | 1.120 |
Why?
|
| von Willebrand Diseases | 7 | 2013 | 135 | 1.110 |
Why?
|
| Thrombocytopenia | 9 | 2013 | 1181 | 1.100 |
Why?
|
| Disease Models, Animal | 38 | 2024 | 18366 | 1.090 |
Why?
|
| Hemorrhage | 10 | 2024 | 3465 | 1.040 |
Why?
|
| Carcinoma, Lewis Lung | 3 | 2018 | 108 | 1.000 |
Why?
|
| Platelet Activation | 21 | 2016 | 644 | 1.000 |
Why?
|
| Peritonitis | 9 | 2022 | 368 | 0.980 |
Why?
|
| Capillary Permeability | 8 | 2018 | 773 | 0.950 |
Why?
|
| Cell Adhesion Molecules | 15 | 2007 | 1614 | 0.910 |
Why?
|
| Fibronectins | 14 | 2007 | 724 | 0.890 |
Why?
|
| Leukotriene B4 | 2 | 2023 | 281 | 0.880 |
Why?
|
| Inflammation | 27 | 2024 | 10869 | 0.880 |
Why?
|
| Hemostasis | 13 | 2016 | 468 | 0.860 |
Why?
|
| Endothelium | 19 | 2007 | 768 | 0.830 |
Why?
|
| Arteriosclerosis | 9 | 2002 | 1056 | 0.830 |
Why?
|
| Platelet Aggregation | 13 | 2018 | 769 | 0.830 |
Why?
|
| Membrane Glycoproteins | 14 | 2016 | 3714 | 0.810 |
Why?
|
| Intercellular Adhesion Molecule-1 | 11 | 2018 | 1133 | 0.810 |
Why?
|
| Weibel-Palade Bodies | 7 | 2017 | 19 | 0.800 |
Why?
|
| Cell Adhesion | 36 | 2012 | 3102 | 0.790 |
Why?
|
| Chemotaxis | 2 | 2023 | 600 | 0.780 |
Why?
|
| Vena Cava, Inferior | 3 | 2020 | 463 | 0.760 |
Why?
|
| Arthritis, Experimental | 2 | 2022 | 293 | 0.760 |
Why?
|
| Interleukin-1beta | 2 | 2024 | 1027 | 0.740 |
Why?
|
| Arterioles | 9 | 2008 | 252 | 0.720 |
Why?
|
| Guanine Nucleotide Exchange Factors | 6 | 2011 | 572 | 0.710 |
Why?
|
| Blood Coagulation | 15 | 2018 | 1161 | 0.700 |
Why?
|
| DNA | 15 | 2020 | 7214 | 0.700 |
Why?
|
| Fibrinogen | 6 | 2021 | 892 | 0.690 |
Why?
|
| Atherosclerosis | 5 | 2022 | 3431 | 0.690 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2011 | 692 | 0.660 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2013 | 484 | 0.660 |
Why?
|
| Serotonin | 4 | 2013 | 1045 | 0.650 |
Why?
|
| Leukocyte Rolling | 7 | 2012 | 69 | 0.630 |
Why?
|
| Myocardium | 4 | 2024 | 4790 | 0.620 |
Why?
|
| Cytoplasmic Granules | 12 | 1999 | 574 | 0.590 |
Why?
|
| Chromatin | 7 | 2020 | 2981 | 0.580 |
Why?
|
| Venules | 10 | 2012 | 161 | 0.580 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2013 | 359 | 0.580 |
Why?
|
| Sirtuin 3 | 1 | 2017 | 66 | 0.570 |
Why?
|
| Vasculitis | 3 | 2017 | 525 | 0.570 |
Why?
|
| Integrins | 7 | 2011 | 843 | 0.550 |
Why?
|
| Calcium Signaling | 1 | 2021 | 738 | 0.540 |
Why?
|
| Blood Vessels | 6 | 2010 | 1110 | 0.530 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2015 | 124 | 0.530 |
Why?
|
| Tryptophan Hydroxylase | 2 | 2013 | 94 | 0.520 |
Why?
|
| Integrin beta3 | 5 | 2007 | 120 | 0.510 |
Why?
|
| Vascular System Injuries | 1 | 2019 | 248 | 0.510 |
Why?
|
| Factor VIII | 4 | 2010 | 349 | 0.510 |
Why?
|
| Apolipoproteins E | 5 | 2009 | 1461 | 0.510 |
Why?
|
| Endotoxemia | 2 | 2015 | 198 | 0.500 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 2014 | 577 | 0.500 |
Why?
|
| Selectins | 6 | 1999 | 101 | 0.490 |
Why?
|
| Reactive Oxygen Species | 5 | 2017 | 2149 | 0.490 |
Why?
|
| Protein Precursors | 11 | 1994 | 1135 | 0.480 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2012 | 85 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 14 | 2019 | 6232 | 0.460 |
Why?
|
| Recombinant Proteins | 13 | 2018 | 6512 | 0.440 |
Why?
|
| Lung Diseases | 2 | 2024 | 1943 | 0.430 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 3 | 2007 | 22 | 0.430 |
Why?
|
| Fibrinolytic Agents | 6 | 2017 | 2080 | 0.430 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2010 | 660 | 0.420 |
Why?
|
| Mice, Transgenic | 18 | 2019 | 9564 | 0.410 |
Why?
|
| Blood Preservation | 5 | 2011 | 169 | 0.410 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 1526 | 0.410 |
Why?
|
| Endothelial Cells | 5 | 2022 | 3591 | 0.410 |
Why?
|
| Caspase 1 | 3 | 2022 | 227 | 0.400 |
Why?
|
| Immunity, Innate | 9 | 2022 | 3080 | 0.400 |
Why?
|
| Cytoprotection | 1 | 2012 | 200 | 0.390 |
Why?
|
| Mice, Inbred DBA | 2 | 2023 | 624 | 0.390 |
Why?
|
| Thromboplastin | 5 | 2012 | 288 | 0.390 |
Why?
|
| Blood Cells | 2 | 2008 | 309 | 0.380 |
Why?
|
| Collagen | 10 | 2022 | 2646 | 0.370 |
Why?
|
| Metalloproteases | 3 | 2011 | 60 | 0.370 |
Why?
|
| Astrocytes | 1 | 2018 | 1349 | 0.360 |
Why?
|
| Apolipoprotein A-I | 1 | 2012 | 305 | 0.360 |
Why?
|
| Mice, Mutant Strains | 12 | 2011 | 1755 | 0.350 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 3 | 2007 | 131 | 0.350 |
Why?
|
| Deoxyribonuclease I | 4 | 2018 | 228 | 0.350 |
Why?
|
| Blotting, Western | 9 | 2015 | 5035 | 0.350 |
Why?
|
| Thrombin | 10 | 2016 | 600 | 0.350 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1282 | 0.340 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2012 | 3814 | 0.340 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 3780 | 0.340 |
Why?
|
| X-Ray Microtomography | 2 | 2022 | 457 | 0.340 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2009 | 6 | 0.330 |
Why?
|
| Histamine | 5 | 2017 | 496 | 0.330 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 6 | 2009 | 692 | 0.330 |
Why?
|
| Umbilical Veins | 13 | 2005 | 425 | 0.330 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 544 | 0.320 |
Why?
|
| Wound Healing | 5 | 2015 | 2815 | 0.320 |
Why?
|
| Male | 76 | 2024 | 365249 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1124 | 0.320 |
Why?
|
| Graft Survival | 1 | 2019 | 3888 | 0.310 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 633 | 0.310 |
Why?
|
| Nucleosomes | 6 | 2018 | 492 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2015 | 3518 | 0.310 |
Why?
|
| Flow Cytometry | 11 | 2015 | 5905 | 0.310 |
Why?
|
| Peroxiredoxins | 1 | 2008 | 51 | 0.310 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 378 | 0.300 |
Why?
|
| Humans | 137 | 2024 | 768887 | 0.300 |
Why?
|
| Monocytes | 8 | 2016 | 2603 | 0.300 |
Why?
|
| Fibrosis | 4 | 2020 | 2081 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 506 | 0.300 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 3941 | 0.290 |
Why?
|
| Status Epilepticus | 1 | 2013 | 463 | 0.290 |
Why?
|
| Platelet Transfusion | 3 | 2009 | 301 | 0.290 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2022 | 631 | 0.290 |
Why?
|
| HL-60 Cells | 6 | 2021 | 364 | 0.290 |
Why?
|
| rap1 GTP-Binding Proteins | 5 | 2011 | 51 | 0.290 |
Why?
|
| Gait | 1 | 2013 | 822 | 0.290 |
Why?
|
| Blood Coagulation Factors | 6 | 1985 | 371 | 0.290 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 686 | 0.290 |
Why?
|
| Citrulline | 3 | 2018 | 107 | 0.280 |
Why?
|
| Photochemistry | 1 | 2007 | 238 | 0.280 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2260 | 0.280 |
Why?
|
| Veins | 3 | 2010 | 769 | 0.280 |
Why?
|
| Cells, Cultured | 36 | 2017 | 19023 | 0.280 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 2053 | 0.270 |
Why?
|
| Erythrocytes | 2 | 2013 | 2421 | 0.270 |
Why?
|
| Heart Failure | 2 | 2023 | 11879 | 0.270 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2005 | 27 | 0.260 |
Why?
|
| Solubility | 6 | 2018 | 1087 | 0.260 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3840 | 0.250 |
Why?
|
| Brain Infarction | 1 | 2007 | 288 | 0.250 |
Why?
|
| Melanoma, Experimental | 1 | 2008 | 559 | 0.240 |
Why?
|
| Organelles | 3 | 1993 | 265 | 0.240 |
Why?
|
| Macrophage-1 Antigen | 5 | 2006 | 286 | 0.240 |
Why?
|
| Stroke | 4 | 2012 | 9756 | 0.240 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 11521 | 0.240 |
Why?
|
| Terpenes | 1 | 2024 | 102 | 0.230 |
Why?
|
| Cerebral Infarction | 2 | 2009 | 975 | 0.230 |
Why?
|
| L-Selectin | 6 | 2012 | 212 | 0.230 |
Why?
|
| CD40 Ligand | 2 | 2005 | 528 | 0.230 |
Why?
|
| Neoplasms | 7 | 2022 | 22390 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 8 | 2008 | 3775 | 0.220 |
Why?
|
| Cell Movement | 11 | 2009 | 5216 | 0.220 |
Why?
|
| Cytoskeleton | 6 | 2020 | 1180 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 7 | 2018 | 2709 | 0.220 |
Why?
|
| Prothrombin | 2 | 2016 | 194 | 0.220 |
Why?
|
| Paclitaxel | 1 | 2011 | 1735 | 0.210 |
Why?
|
| Brain Ischemia | 2 | 2016 | 3008 | 0.210 |
Why?
|
| Macromolecular Substances | 15 | 1993 | 1435 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1813 | 0.210 |
Why?
|
| Gene Expression Regulation | 7 | 2008 | 11934 | 0.210 |
Why?
|
| Disintegrins | 1 | 2022 | 27 | 0.210 |
Why?
|
| Splanchnic Circulation | 2 | 2006 | 122 | 0.210 |
Why?
|
| Ferric Compounds | 4 | 2012 | 377 | 0.200 |
Why?
|
| Nuclear Envelope | 2 | 2020 | 163 | 0.200 |
Why?
|
| Lipopolysaccharides | 5 | 2015 | 2222 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2024 | 665 | 0.200 |
Why?
|
| Homocysteine | 1 | 2005 | 637 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2011 | 1966 | 0.200 |
Why?
|
| Bleeding Time | 5 | 2006 | 83 | 0.200 |
Why?
|
| Plasminogen Inactivators | 1 | 2021 | 37 | 0.190 |
Why?
|
| Bernard-Soulier Syndrome | 1 | 2001 | 7 | 0.190 |
Why?
|
| Chlorides | 4 | 2012 | 666 | 0.190 |
Why?
|
| Crosses, Genetic | 3 | 2015 | 752 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1890 | 0.190 |
Why?
|
| Receptors, LDL | 3 | 2001 | 492 | 0.190 |
Why?
|
| Female | 56 | 2024 | 397464 | 0.180 |
Why?
|
| Time Factors | 15 | 2018 | 40266 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 12 | 1998 | 2475 | 0.180 |
Why?
|
| Interleukin-11 | 1 | 2001 | 59 | 0.180 |
Why?
|
| Antigens, CD | 6 | 2007 | 4032 | 0.180 |
Why?
|
| Sepsis | 1 | 2015 | 2609 | 0.180 |
Why?
|
| Antigens | 5 | 2007 | 1444 | 0.180 |
Why?
|
| Dermatitis, Contact | 2 | 2005 | 134 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3233 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 583 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3744 | 0.180 |
Why?
|
| Fibrin | 6 | 2004 | 514 | 0.170 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 174 | 0.170 |
Why?
|
| Transfection | 10 | 2012 | 5763 | 0.170 |
Why?
|
| Refrigeration | 2 | 2011 | 27 | 0.170 |
Why?
|
| Hemophilia A | 1 | 2003 | 359 | 0.170 |
Why?
|
| Fibrinolysis | 1 | 2021 | 331 | 0.170 |
Why?
|
| Ligands | 8 | 2007 | 3283 | 0.170 |
Why?
|
| Extracellular Matrix | 6 | 2013 | 1739 | 0.170 |
Why?
|
| Carboxypeptidases | 1 | 1999 | 121 | 0.170 |
Why?
|
| Extracellular Space | 4 | 2014 | 566 | 0.170 |
Why?
|
| Skin | 9 | 2012 | 4507 | 0.160 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3163 | 0.160 |
Why?
|
| Aptamers, Nucleotide | 2 | 2012 | 163 | 0.160 |
Why?
|
| Hepatitis, Animal | 1 | 1998 | 19 | 0.160 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2000 | 108 | 0.160 |
Why?
|
| Molecular Weight | 13 | 1997 | 2173 | 0.160 |
Why?
|
| Cell Degranulation | 3 | 2017 | 277 | 0.160 |
Why?
|
| Cricetinae | 10 | 2012 | 2423 | 0.160 |
Why?
|
| Preoptic Area | 1 | 2000 | 132 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 2892 | 0.160 |
Why?
|
| Calcimycin | 7 | 2000 | 214 | 0.160 |
Why?
|
| Depression | 1 | 2018 | 8240 | 0.160 |
Why?
|
| Leukocytosis | 3 | 2012 | 251 | 0.150 |
Why?
|
| Antithrombins | 1 | 2021 | 294 | 0.150 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 4835 | 0.150 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 289 | 0.150 |
Why?
|
| Fasting | 1 | 2004 | 1610 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2008 | 4356 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3138 | 0.150 |
Why?
|
| Embolism | 1 | 2001 | 401 | 0.150 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1997 | 53 | 0.150 |
Why?
|
| Shwartzman Phenomenon | 3 | 2006 | 9 | 0.150 |
Why?
|
| Signal Transduction | 13 | 2018 | 23652 | 0.140 |
Why?
|
| Microscopy, Immunoelectron | 4 | 2000 | 316 | 0.140 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 127 | 0.140 |
Why?
|
| Microscopy, Electron | 4 | 2009 | 2560 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2003 | 1004 | 0.140 |
Why?
|
| Membrane Proteins | 5 | 2007 | 7885 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2018 | 10778 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2012 | 1165 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.130 |
Why?
|
| Evans Blue | 2 | 2006 | 42 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 2203 | 0.130 |
Why?
|
| Endocytosis | 3 | 2012 | 959 | 0.130 |
Why?
|
| CHO Cells | 5 | 2012 | 1380 | 0.130 |
Why?
|
| Enzyme Precursors | 1 | 2016 | 166 | 0.130 |
Why?
|
| Bone Marrow | 3 | 2007 | 2935 | 0.130 |
Why?
|
| Mice, Inbred Strains | 7 | 2008 | 1769 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1904 | 0.130 |
Why?
|
| Cell Communication | 4 | 2012 | 1660 | 0.130 |
Why?
|
| Ionomycin | 1 | 2015 | 110 | 0.130 |
Why?
|
| Mast Cells | 3 | 2017 | 1406 | 0.130 |
Why?
|
| Cell Membrane | 7 | 2020 | 3659 | 0.120 |
Why?
|
| Fibrinopeptide B | 3 | 1992 | 4 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 559 | 0.120 |
Why?
|
| Phenotype | 9 | 2022 | 16735 | 0.120 |
Why?
|
| Adiposity | 1 | 2005 | 1895 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2008 | 2029 | 0.120 |
Why?
|
| Transplantation Immunology | 2 | 2012 | 537 | 0.120 |
Why?
|
| Thioglycolates | 3 | 2005 | 37 | 0.120 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 2004 | 22 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2018 | 425 | 0.120 |
Why?
|
| Microtubules | 4 | 2020 | 1062 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2000 | 951 | 0.110 |
Why?
|
| alpha-Linolenic Acid | 1 | 2014 | 144 | 0.110 |
Why?
|
| Skin Window Technique | 2 | 2012 | 22 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 642 | 0.110 |
Why?
|
| Pilocarpine | 1 | 2013 | 64 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2015 | 3724 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 255 | 0.110 |
Why?
|
| Megakaryocytes | 3 | 2007 | 571 | 0.110 |
Why?
|
| Microscopy | 2 | 2012 | 909 | 0.110 |
Why?
|
| Obesity | 3 | 2024 | 13087 | 0.110 |
Why?
|
| Peroxidase | 3 | 2012 | 610 | 0.110 |
Why?
|
| Heterozygote | 3 | 2006 | 2798 | 0.110 |
Why?
|
| Arthus Reaction | 1 | 2012 | 14 | 0.110 |
Why?
|
| Liver | 5 | 2005 | 7579 | 0.100 |
Why?
|
| Acute Disease | 5 | 2012 | 7245 | 0.100 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2008 | 746 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 506 | 0.100 |
Why?
|
| Sex Factors | 2 | 2024 | 10641 | 0.100 |
Why?
|
| Brain | 6 | 2016 | 27476 | 0.100 |
Why?
|
| Biological Assay | 1 | 2015 | 628 | 0.100 |
Why?
|
| Base Sequence | 10 | 2010 | 12430 | 0.100 |
Why?
|
| Meningitis | 3 | 2001 | 219 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2012 | 4148 | 0.100 |
Why?
|
| Influenza A virus | 1 | 2016 | 460 | 0.100 |
Why?
|
| Afibrinogenemia | 2 | 2003 | 17 | 0.100 |
Why?
|
| Aptamers, Peptide | 1 | 2012 | 28 | 0.100 |
Why?
|
| Metabolome | 1 | 2019 | 1009 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2012 | 194 | 0.100 |
Why?
|
| Macrophages | 7 | 2009 | 5800 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1999 | 3408 | 0.100 |
Why?
|
| Microcirculation | 3 | 2014 | 1281 | 0.100 |
Why?
|
| Mesenteric Veins | 3 | 2009 | 87 | 0.100 |
Why?
|
| Heme | 1 | 2014 | 316 | 0.100 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 93 | 0.100 |
Why?
|
| Cell Line | 12 | 2009 | 15603 | 0.100 |
Why?
|
| Myeloproliferative Disorders | 1 | 2018 | 616 | 0.100 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1617 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 534 | 0.090 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4940 | 0.090 |
Why?
|
| Benzimidazoles | 2 | 2015 | 864 | 0.090 |
Why?
|
| Disulfides | 4 | 1989 | 467 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2011 | 196 | 0.090 |
Why?
|
| Cell Count | 2 | 2009 | 1833 | 0.090 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1036 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 10 | 2006 | 9264 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 1993 | 419 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2008 | 1531 | 0.090 |
Why?
|
| Bacterial Infections | 2 | 2016 | 1397 | 0.090 |
Why?
|
| Cell Fractionation | 4 | 1993 | 247 | 0.090 |
Why?
|
| Growth Substances | 3 | 1998 | 760 | 0.090 |
Why?
|
| Aging | 3 | 2006 | 8765 | 0.090 |
Why?
|
| Proteoglycans | 2 | 2006 | 809 | 0.090 |
Why?
|
| Troponin T | 1 | 2016 | 787 | 0.090 |
Why?
|
| Computer Systems | 1 | 2012 | 470 | 0.090 |
Why?
|
| Tight Junctions | 1 | 2013 | 324 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 513 | 0.090 |
Why?
|
| Adenosine Diphosphate | 3 | 2008 | 422 | 0.090 |
Why?
|
| Sinus of Valsalva | 2 | 2001 | 60 | 0.090 |
Why?
|
| Cricetulus | 1 | 2012 | 813 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 1998 | 1371 | 0.090 |
Why?
|
| Insulin | 2 | 2004 | 6610 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 3 | 2009 | 2634 | 0.090 |
Why?
|
| Tissue Distribution | 3 | 2011 | 2299 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10276 | 0.090 |
Why?
|
| Blood Donors | 1 | 2012 | 344 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 2862 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2001 | 2058 | 0.080 |
Why?
|
| Fluorescence | 1 | 2012 | 758 | 0.080 |
Why?
|
| Protein Binding | 7 | 2012 | 9344 | 0.080 |
Why?
|
| Molecular Sequence Data | 9 | 1996 | 17629 | 0.080 |
Why?
|
| Hemorheology | 3 | 2012 | 144 | 0.080 |
Why?
|
| Diet, Atherogenic | 2 | 2001 | 92 | 0.080 |
Why?
|
| Isoflurane | 1 | 2012 | 384 | 0.080 |
Why?
|
| Cell Death | 2 | 2018 | 1682 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 2433 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2012 | 564 | 0.080 |
Why?
|
| Phospholipases A2 | 1 | 2009 | 197 | 0.080 |
Why?
|
| Aorta | 4 | 2003 | 2046 | 0.080 |
Why?
|
| Cysteine | 2 | 2003 | 897 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 706 | 0.080 |
Why?
|
| Monensin | 2 | 1985 | 30 | 0.080 |
Why?
|
| Fluoxetine | 1 | 2012 | 735 | 0.080 |
Why?
|
| Memory | 1 | 2018 | 2210 | 0.080 |
Why?
|
| Disease Progression | 5 | 2019 | 13677 | 0.080 |
Why?
|
| Blood Circulation | 2 | 2012 | 248 | 0.080 |
Why?
|
| Motor Activity | 1 | 2018 | 2722 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2011 | 11119 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 1996 | 1162 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 1014 | 0.080 |
Why?
|
| Shiga Toxins | 1 | 2007 | 39 | 0.080 |
Why?
|
| Mesentery | 3 | 2008 | 202 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 1 | 2008 | 88 | 0.070 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2008 | 97 | 0.070 |
Why?
|
| Angiopoietin-1 | 1 | 2008 | 134 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 17174 | 0.070 |
Why?
|
| Models, Biological | 5 | 2009 | 9499 | 0.070 |
Why?
|
| Bacteremia | 1 | 2015 | 985 | 0.070 |
Why?
|
| DNA Primers | 4 | 2010 | 2827 | 0.070 |
Why?
|
| Leukotrienes | 1 | 2009 | 232 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13699 | 0.070 |
Why?
|
| Genotype | 4 | 2013 | 13048 | 0.070 |
Why?
|
| Cytokines | 7 | 2006 | 7453 | 0.070 |
Why?
|
| Complement Activation | 1 | 2009 | 447 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2012 | 573 | 0.070 |
Why?
|
| Medical Illustration | 1 | 2008 | 135 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3588 | 0.070 |
Why?
|
| Graft Rejection | 2 | 2019 | 4492 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2008 | 205 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2006 | 2202 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1339 | 0.070 |
Why?
|
| Rats | 9 | 2012 | 23847 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 2007 | 2820 | 0.070 |
Why?
|
| Amino Acids | 2 | 1992 | 1716 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 1705 | 0.070 |
Why?
|
| Platelet Function Tests | 2 | 2012 | 275 | 0.070 |
Why?
|
| Leukocyte Elastase | 1 | 2007 | 114 | 0.070 |
Why?
|
| Antibodies, Blocking | 2 | 1997 | 250 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2010 | 639 | 0.070 |
Why?
|
| Peptide Fragments | 6 | 1992 | 5150 | 0.070 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2006 | 34 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 1996 | 2059 | 0.070 |
Why?
|
| Semaphorins | 1 | 2007 | 96 | 0.070 |
Why?
|
| Pulmonary Embolism | 2 | 2012 | 2598 | 0.070 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 57 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2006 | 241 | 0.070 |
Why?
|
| Cornea | 3 | 2006 | 1315 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1550 | 0.070 |
Why?
|
| Hemodynamics | 4 | 2012 | 4199 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3124 | 0.070 |
Why?
|
| Pancreatic Elastase | 1 | 2006 | 125 | 0.070 |
Why?
|
| Peptide Hydrolases | 3 | 2021 | 610 | 0.070 |
Why?
|
| Actins | 3 | 2010 | 2065 | 0.070 |
Why?
|
| Cryptosporidiosis | 1 | 2006 | 52 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1907 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2015 | 6434 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2012 | 774 | 0.070 |
Why?
|
| Stress, Mechanical | 2 | 2012 | 1680 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 18454 | 0.060 |
Why?
|
| Haploidy | 1 | 2006 | 127 | 0.060 |
Why?
|
| Necrosis | 2 | 2008 | 1621 | 0.060 |
Why?
|
| Thrombopoiesis | 1 | 2007 | 166 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2231 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2008 | 715 | 0.060 |
Why?
|
| Homeostasis | 3 | 2009 | 3348 | 0.060 |
Why?
|
| Galactose | 1 | 2007 | 300 | 0.060 |
Why?
|
| Shiga Toxin | 1 | 2005 | 36 | 0.060 |
Why?
|
| Dinitrofluorobenzene | 1 | 2005 | 14 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 742 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2010 | 724 | 0.060 |
Why?
|
| Coagulants | 1 | 2005 | 45 | 0.060 |
Why?
|
| Cell Migration Inhibition | 2 | 2005 | 97 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 1065 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1990 | 905 | 0.060 |
Why?
|
| Mannose-Binding Lectin | 1 | 2006 | 146 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2139 | 0.060 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 2005 | 89 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 1993 | 1266 | 0.060 |
Why?
|
| Vasodilation | 1 | 2009 | 967 | 0.060 |
Why?
|
| Austria | 2 | 2018 | 209 | 0.060 |
Why?
|
| Particle Size | 1 | 2009 | 1652 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2016 | 1541 | 0.060 |
Why?
|
| Golgi Apparatus | 3 | 1994 | 407 | 0.060 |
Why?
|
| Hematology | 1 | 2008 | 243 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.060 |
Why?
|
| Laminin | 1 | 2006 | 406 | 0.060 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2005 | 169 | 0.060 |
Why?
|
| Blood Coagulation Tests | 1 | 2005 | 270 | 0.060 |
Why?
|
| Globins | 1 | 2005 | 405 | 0.060 |
Why?
|
| Exocytosis | 2 | 2003 | 323 | 0.060 |
Why?
|
| Cold Temperature | 3 | 2004 | 791 | 0.060 |
Why?
|
| Furans | 1 | 1985 | 202 | 0.060 |
Why?
|
| Furosemide | 1 | 2005 | 174 | 0.060 |
Why?
|
| omega-N-Methylarginine | 1 | 2003 | 108 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2004 | 176 | 0.060 |
Why?
|
| Kinetics | 6 | 2008 | 6334 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2003 | 12174 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2007 | 320 | 0.060 |
Why?
|
| Second Messenger Systems | 1 | 2004 | 204 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2006 | 539 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2007 | 1530 | 0.050 |
Why?
|
| Ammonium Chloride | 3 | 1989 | 72 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1207 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 682 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4677 | 0.050 |
Why?
|
| Tubulin | 2 | 2003 | 695 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 6131 | 0.050 |
Why?
|
| Cholesterol | 3 | 2008 | 2913 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3538 | 0.050 |
Why?
|
| Arteries | 2 | 2009 | 1126 | 0.050 |
Why?
|
| Wakefulness | 2 | 2000 | 1284 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2009 | 2004 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 254 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 822 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1992 | 849 | 0.050 |
Why?
|
| Antibodies | 3 | 2006 | 2422 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12798 | 0.050 |
Why?
|
| Glycosylation | 3 | 2011 | 1101 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1992 | 1731 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 2004 | 2226 | 0.050 |
Why?
|
| Gene Expression | 4 | 2000 | 7602 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1494 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 394 | 0.050 |
Why?
|
| Multiprotein Complexes | 2 | 2007 | 1111 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2012 | 2763 | 0.050 |
Why?
|
| Dipeptides | 1 | 2004 | 386 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 1985 | 693 | 0.050 |
Why?
|
| Transgenes | 1 | 2006 | 1016 | 0.050 |
Why?
|
| Introns | 1 | 2005 | 969 | 0.050 |
Why?
|
| Young Adult | 3 | 2019 | 60110 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 515 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6546 | 0.050 |
Why?
|
| Swine | 4 | 2012 | 5998 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2002 | 222 | 0.050 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2004 | 384 | 0.050 |
Why?
|
| Bone Marrow Cells | 3 | 2006 | 2414 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2592 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2004 | 483 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 1987 | 1027 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3442 | 0.050 |
Why?
|
| Alleles | 4 | 2016 | 6901 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 2488 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 584 | 0.050 |
Why?
|
| Salmonella | 1 | 2001 | 125 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2024 | 9384 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 626 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2238 | 0.050 |
Why?
|
| Ionophores | 1 | 2000 | 108 | 0.050 |
Why?
|
| Echocardiography | 1 | 2013 | 5046 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 377 | 0.050 |
Why?
|
| Trypsin | 3 | 1992 | 491 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1105 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 2004 | 350 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 911 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2021 | 250 | 0.040 |
Why?
|
| Tunicamycin | 3 | 1992 | 109 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2012 | 1989 | 0.040 |
Why?
|
| Calcium | 3 | 2015 | 5792 | 0.040 |
Why?
|
| Antioxidants | 1 | 2008 | 1673 | 0.040 |
Why?
|
| Genes, fos | 1 | 2000 | 176 | 0.040 |
Why?
|
| Neurons | 1 | 2000 | 9524 | 0.040 |
Why?
|
| Cell Compartmentation | 4 | 1989 | 383 | 0.040 |
Why?
|
| Carboxypeptidase H | 1 | 1999 | 9 | 0.040 |
Why?
|
| Corneal Neovascularization | 1 | 2002 | 184 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 530 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 838 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 4415 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2771 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2003 | 855 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1057 | 0.040 |
Why?
|
| Galanin | 1 | 2000 | 42 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 873 | 0.040 |
Why?
|
| Cytosol | 2 | 2020 | 886 | 0.040 |
Why?
|
| Brain Edema | 1 | 2004 | 607 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6413 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2001 | 179 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 1956 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2006 | 2088 | 0.040 |
Why?
|
| Intestines | 1 | 2008 | 1911 | 0.040 |
Why?
|
| Remission Induction | 2 | 2018 | 2411 | 0.040 |
Why?
|
| Blood Cell Count | 2 | 2014 | 406 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1999 | 40 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 18065 | 0.040 |
Why?
|
| Cesium Radioisotopes | 1 | 1998 | 38 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1998 | 594 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 1676 | 0.040 |
Why?
|
| Cerebellum | 1 | 2006 | 1522 | 0.040 |
Why?
|
| Thrombelastography | 1 | 2021 | 194 | 0.040 |
Why?
|
| Complement C3 | 3 | 2008 | 434 | 0.040 |
Why?
|
| Fish Oils | 1 | 2002 | 483 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 1994 | 13427 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2018 | 22294 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1998 | 96 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2009 | 1609 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 829 | 0.040 |
Why?
|
| Meat | 1 | 2001 | 588 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15955 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 1998 | 351 | 0.040 |
Why?
|
| Cats | 1 | 2000 | 978 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2002 | 703 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10486 | 0.040 |
Why?
|
| Macaca fascicularis | 2 | 2012 | 913 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 1683 | 0.040 |
Why?
|
| Lung | 4 | 2014 | 10097 | 0.040 |
Why?
|
| Chimera | 2 | 2003 | 454 | 0.040 |
Why?
|
| Platelet Count | 1 | 2001 | 787 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2009 | 8317 | 0.040 |
Why?
|
| Simplexvirus | 1 | 1981 | 805 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 201 | 0.040 |
Why?
|
| Electromyography | 2 | 2000 | 1402 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1999 | 286 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 859 | 0.040 |
Why?
|
| Selenoprotein P | 1 | 2017 | 33 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 3 | 1991 | 1133 | 0.040 |
Why?
|
| Aged | 8 | 2019 | 171790 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 2001 | 455 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 1997 | 113 | 0.040 |
Why?
|
| Granulation Tissue | 1 | 1997 | 92 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 1410 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 189 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2004 | 1246 | 0.040 |
Why?
|
| Eosinophils | 2 | 1999 | 953 | 0.040 |
Why?
|
| Splenectomy | 1 | 1998 | 392 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1998 | 208 | 0.030 |
Why?
|
| Perches | 1 | 1996 | 27 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2018 | 253 | 0.030 |
Why?
|
| Apyrase | 1 | 1999 | 376 | 0.030 |
Why?
|
| Radiography | 1 | 2008 | 6991 | 0.030 |
Why?
|
| Clot Retraction | 1 | 2016 | 13 | 0.030 |
Why?
|
| Binding Sites | 2 | 2003 | 6023 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2000 | 2593 | 0.030 |
Why?
|
| Crotalid Venoms | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pneumonia, Aspiration | 1 | 1997 | 145 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1997 | 224 | 0.030 |
Why?
|
| Ligation | 1 | 2017 | 446 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 13593 | 0.030 |
Why?
|
| Caspases, Initiator | 1 | 2016 | 31 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15662 | 0.030 |
Why?
|
| Cattle | 3 | 2002 | 3820 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1997 | 491 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7472 | 0.030 |
Why?
|
| Dermatitis | 1 | 1998 | 203 | 0.030 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2007 | 51 | 0.030 |
Why?
|
| Keratinocytes | 2 | 1998 | 876 | 0.030 |
Why?
|
| Middle Aged | 10 | 2018 | 223740 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2018 | 459 | 0.030 |
Why?
|
| Breath Tests | 1 | 1997 | 300 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1995 | 110 | 0.030 |
Why?
|
| Ethylmaleimide | 2 | 1989 | 69 | 0.030 |
Why?
|
| Transcription Factor RelB | 1 | 1995 | 29 | 0.030 |
Why?
|
| Hirudins | 2 | 2006 | 179 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2277 | 0.030 |
Why?
|
| Oxazolone | 1 | 1995 | 61 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 1794 | 0.030 |
Why?
|
| Phenylalanine | 1 | 1997 | 368 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2001 | 741 | 0.030 |
Why?
|
| Proteomics | 1 | 2009 | 3913 | 0.030 |
Why?
|
| Species Specificity | 1 | 2000 | 2419 | 0.030 |
Why?
|
| Splenomegaly | 1 | 1996 | 192 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2005 | 1789 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1999 | 842 | 0.030 |
Why?
|
| Biological Transport | 1 | 1999 | 2085 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2000 | 841 | 0.030 |
Why?
|
| Adult | 10 | 2016 | 223818 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1998 | 643 | 0.030 |
Why?
|
| Transplantation | 1 | 1996 | 221 | 0.030 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 1996 | 204 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1982 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2016 | 169 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 824 | 0.030 |
Why?
|
| Auditory Pathways | 1 | 1997 | 238 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 560 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 1998 | 348 | 0.030 |
Why?
|
| Dogs | 1 | 1999 | 3845 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5544 | 0.030 |
Why?
|
| Genetic Engineering | 2 | 1999 | 936 | 0.030 |
Why?
|
| Ulcer | 1 | 1996 | 203 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1998 | 1229 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2003 | 2149 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 1439 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1999 | 943 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6085 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4291 | 0.030 |
Why?
|
| Sleep | 2 | 2000 | 4820 | 0.030 |
Why?
|
| Glomerulonephritis | 1 | 1996 | 333 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2016 | 349 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1998 | 1505 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 573 | 0.030 |
Why?
|
| Heparin | 1 | 2001 | 1636 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2018 | 408 | 0.030 |
Why?
|
| Diet | 2 | 2005 | 8090 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1999 | 877 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1993 | 152 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3135 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5801 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1992 | 525 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2015 | 1751 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 1142 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 725 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6569 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 2 | 2006 | 393 | 0.030 |
Why?
|
| Neutropenia | 1 | 1998 | 893 | 0.030 |
Why?
|
| Lipoxins | 1 | 1996 | 419 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 1667 | 0.030 |
Why?
|
| Sulfates | 1 | 1994 | 379 | 0.030 |
Why?
|
| Caspases | 1 | 2016 | 881 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 931 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2002 | 1399 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 990 | 0.030 |
Why?
|
| Genes, Plant | 1 | 1992 | 129 | 0.030 |
Why?
|
| Latex | 2 | 1982 | 49 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14751 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2012 | 115 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1936 | 0.030 |
Why?
|
| Visual Pathways | 1 | 1997 | 559 | 0.030 |
Why?
|
| Factor XII | 1 | 2012 | 20 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1992 | 73 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 1363 | 0.020 |
Why?
|
| Complement Pathway, Classical | 2 | 2005 | 91 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1997 | 880 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1979 | 2848 | 0.020 |
Why?
|
| Quebec | 1 | 2012 | 139 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2012 | 178 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 5455 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1999 | 2674 | 0.020 |
Why?
|
| Stem Cells | 2 | 1996 | 3540 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1992 | 373 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 249 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1998 | 1506 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 878 | 0.020 |
Why?
|
| Drug Stability | 1 | 2012 | 292 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2020 | 2885 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2011 | 176 | 0.020 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 120 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1992 | 816 | 0.020 |
Why?
|
| Biological Availability | 1 | 2012 | 392 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2011 | 42 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2006 | 5107 | 0.020 |
Why?
|
| Fibrinopeptide A | 2 | 1989 | 43 | 0.020 |
Why?
|
| Autoradiography | 1 | 1992 | 732 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 131 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2012 | 408 | 0.020 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 108 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 651 | 0.020 |
Why?
|
| Protein C | 1 | 2011 | 134 | 0.020 |
Why?
|
| Epitopes | 1 | 1997 | 2529 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 173 | 0.020 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 100 | 0.020 |
Why?
|
| Organoids | 2 | 1987 | 745 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 1992 | 577 | 0.020 |
Why?
|
| Mutation | 4 | 1997 | 30266 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 687 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2010 | 88 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1992 | 677 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1992 | 619 | 0.020 |
Why?
|
| Mitochondria | 1 | 2003 | 3683 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2011 | 381 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Pregnancy | 5 | 2016 | 30175 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 458 | 0.020 |
Why?
|
| Phospholipids | 1 | 1993 | 787 | 0.020 |
Why?
|
| Glycine | 1 | 1993 | 672 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 742 | 0.020 |
Why?
|
| Arabidopsis | 1 | 1992 | 469 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1987 | 3956 | 0.020 |
Why?
|
| Dopamine | 1 | 1996 | 1617 | 0.020 |
Why?
|
| Arginine | 1 | 1993 | 932 | 0.020 |
Why?
|
| Triglycerides | 1 | 1997 | 2464 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1997 | 2003 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1993 | 708 | 0.020 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1993 | 1390 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1996 | 2614 | 0.020 |
Why?
|
| Fibroblasts | 4 | 1987 | 4178 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8200 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 683 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2004 | 1942 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1997 | 1305 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3345 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 12809 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 947 | 0.020 |
Why?
|
| Protein Engineering | 1 | 1992 | 553 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2008 | 89 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9618 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2008 | 130 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 930 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2008 | 238 | 0.020 |
Why?
|
| Lumicolchicines | 1 | 1987 | 3 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1986 | 3056 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 921 | 0.020 |
Why?
|
| Nocodazole | 1 | 1987 | 95 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 2029 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2005 | 2941 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1992 | 4168 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2008 | 412 | 0.020 |
Why?
|
| Placenta | 1 | 2016 | 1721 | 0.020 |
Why?
|
| Popliteal Vein | 1 | 2007 | 43 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2000 | 6318 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2008 | 425 | 0.020 |
Why?
|
| Lysosomes | 1 | 1993 | 940 | 0.020 |
Why?
|
| Shear Strength | 1 | 2007 | 160 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 1140 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1900 | 0.020 |
Why?
|
| Viral Load | 1 | 2016 | 3398 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1986 | 20 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1995 | 2492 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1741 | 0.020 |
Why?
|
| Acetylglucosaminidase | 1 | 1986 | 66 | 0.020 |
Why?
|
| Body Patterning | 1 | 2010 | 634 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2635 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2018 | 54950 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1251 | 0.020 |
Why?
|
| Peptides | 2 | 2004 | 4353 | 0.020 |
Why?
|
| Swainsonine | 1 | 1985 | 9 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 266 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 371 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 823 | 0.020 |
Why?
|
| Colchicine | 1 | 1987 | 257 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9621 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3050 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 2269 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 59738 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2911 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 901 | 0.020 |
Why?
|
| Rats, Inbred Lew | 2 | 1997 | 1163 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4926 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 185 | 0.020 |
Why?
|
| Popliteal Artery | 1 | 2007 | 313 | 0.020 |
Why?
|
| Microbodies | 1 | 1984 | 34 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 839 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2015 | 5404 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1880 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2012 | 1360 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1989 | 1885 | 0.010 |
Why?
|
| 2,2'-Dipyridyl | 1 | 1984 | 9 | 0.010 |
Why?
|
| Survival Rate | 1 | 1998 | 12873 | 0.010 |
Why?
|
| Haiti | 1 | 2006 | 553 | 0.010 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Alkaloids | 1 | 1985 | 192 | 0.010 |
Why?
|
| Diglycerides | 1 | 2004 | 176 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2007 | 519 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2009 | 1743 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1984 | 527 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2005 | 338 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2007 | 917 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.010 |
Why?
|
| SNARE Proteins | 1 | 2003 | 80 | 0.010 |
Why?
|
| Microbial Collagenase | 1 | 1984 | 112 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10115 | 0.010 |
Why?
|
| RNA | 1 | 1993 | 2727 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2003 | 262 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 1437 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12563 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 874 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 999 | 0.010 |
Why?
|
| Fluoroimmunoassay | 1 | 2002 | 30 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11262 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 829 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 5794 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1714 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 4528 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2008 | 1194 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 684 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2003 | 143 | 0.010 |
Why?
|
| Syndecans | 1 | 2002 | 75 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2002 | 190 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1524 | 0.010 |
Why?
|
| Temperature | 1 | 1989 | 2235 | 0.010 |
Why?
|
| Turkeys | 1 | 2001 | 44 | 0.010 |
Why?
|
| Cephalosporin Resistance | 1 | 2001 | 17 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2001 | 142 | 0.010 |
Why?
|
| GATA1 Transcription Factor | 1 | 2003 | 306 | 0.010 |
Why?
|
| District of Columbia | 1 | 2001 | 159 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2007 | 5323 | 0.010 |
Why?
|
| Salmonella enterica | 1 | 2001 | 76 | 0.010 |
Why?
|
| Syndecan-1 | 1 | 2002 | 163 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26384 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4593 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1985 | 1081 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 332 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2005 | 1585 | 0.010 |
Why?
|
| Risk Factors | 3 | 2017 | 74971 | 0.010 |
Why?
|
| Ceftriaxone | 1 | 2001 | 175 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 255 | 0.010 |
Why?
|
| Mitochondrial Diseases | 1 | 2004 | 344 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1973 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1981 | 225 | 0.010 |
Why?
|
| Cyanides | 1 | 1980 | 82 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1979 | 17 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 1999 | 40 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 845 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1993 | 7609 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21545 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2483 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1999 | 128 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1173 | 0.010 |
Why?
|
| Rhodamine 123 | 1 | 1998 | 37 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9375 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1999 | 141 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 1999 | 119 | 0.010 |
Why?
|
| Light | 2 | 1996 | 1356 | 0.010 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 1998 | 31 | 0.010 |
Why?
|
| Zymosan | 1 | 1998 | 134 | 0.010 |
Why?
|
| Gingiva | 1 | 2001 | 423 | 0.010 |
Why?
|
| Microspheres | 1 | 1982 | 789 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3438 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2002 | 565 | 0.010 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1999 | 152 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 438 | 0.010 |
Why?
|
| Rhodamines | 1 | 1998 | 178 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39394 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1998 | 175 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1979 | 296 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 74 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1998 | 126 | 0.010 |
Why?
|
| Alveolar Bone Loss | 1 | 2001 | 401 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4941 | 0.010 |
Why?
|
| Transcription Factor Brn-3 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Transcription Factor Brn-3B | 1 | 1997 | 4 | 0.010 |
Why?
|
| Transcription Factor Brn-3A | 1 | 1997 | 13 | 0.010 |
Why?
|
| Virulence | 1 | 2001 | 1298 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3047 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1998 | 915 | 0.010 |
Why?
|
| Body Temperature | 1 | 2000 | 781 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4862 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15471 | 0.010 |
Why?
|
| Darkness | 1 | 1996 | 160 | 0.010 |
Why?
|
| Lipoxygenase | 1 | 1996 | 72 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1998 | 415 | 0.010 |
Why?
|
| Hybridomas | 1 | 1997 | 444 | 0.010 |
Why?
|
| Liposomes | 2 | 1990 | 792 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 2002 | 864 | 0.010 |
Why?
|
| Periodontitis | 1 | 2001 | 577 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 640 | 0.010 |
Why?
|
| Back | 1 | 1995 | 64 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 617 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1997 | 526 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 697 | 0.010 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1996 | 225 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1996 | 348 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 1963 | 0.010 |
Why?
|
| Nervous System Malformations | 1 | 1997 | 243 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2359 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1996 | 284 | 0.010 |
Why?
|
| Ankle Joint | 1 | 1998 | 452 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3839 | 0.010 |
Why?
|
| Heart Transplantation | 2 | 1999 | 3301 | 0.010 |
Why?
|
| Skull | 1 | 1998 | 830 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1996 | 619 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1996 | 569 | 0.010 |
Why?
|
| Epithelium | 1 | 1998 | 1607 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2000 | 848 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 545 | 0.010 |
Why?
|
| Proteinuria | 1 | 1996 | 610 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 1997 | 516 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8559 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6242 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1992 | 363 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1996 | 394 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1992 | 123 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1998 | 1428 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 30044 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 706 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1992 | 945 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 1933 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1991 | 289 | 0.010 |
Why?
|
| Bacteria | 1 | 2001 | 2219 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 388 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20776 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 41800 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 65485 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2843 | 0.000 |
Why?
|
| Papio | 1 | 1991 | 672 | 0.000 |
Why?
|
| Sequence Alignment | 1 | 1992 | 2179 | 0.000 |
Why?
|
| Gene Library | 1 | 1990 | 1062 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1553 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2661 | 0.000 |
Why?
|
| Infant | 1 | 2006 | 36541 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 89247 | 0.000 |
Why?
|
| Proteins | 1 | 1998 | 6011 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2005 | 24330 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20244 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1986 | 1191 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36861 | 0.000 |
Why?
|
| Chemistry | 1 | 1978 | 327 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1978 | 486 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 81892 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1992 | 11684 | 0.000 |
Why?
|